Skip to main content
HALO logo

HALO

Halozyme Therapeutics, Inc.
$77.54 +1.72 (+2.27%) At close · Jul 16
Market Cap
$9.20B
Shares
118,613,000

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 646
Total Value: $7,647,780,067
Total Shares: 117,464,230
Showing 1–100 of 662 holdings by value · page 1 of 7

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 634 13F filers
Top Holder
11.5%
Jun 2023 → Mar 2026 · range 10.6% – 15.0%
of institutional value
Top 5
26.3%
Jun 2023 → Mar 2026 · range 26.3% – 40.4%
of institutional value
Top 10
37.1%
Jun 2023 → Mar 2026 · range 37.1% – 52.8%
of institutional value
HHI
262
Jun 2023 → Mar 2026 · range 262 – 476
Broadly held
Showing 100 of 662
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1159036 CUSIP 40637H109 13F (30d) 78 filings 73 filers Visit website Investor relations